Cargando…

T lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Tang, Li, Zheng, Yiran, Mabardi, Llian, Irvine, Darrell J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645506/ http://dx.doi.org/10.1186/2051-1426-3-S2-P54

Ejemplares similares

Enhancing T cell therapy through TCR signaling-responsive nanoparticle drug delivery
por: Tang, Li, et al.
Publicado: (2018)

Chitosan thermogels for local T lymphocyte delivery for cancer immunotherapy
por: Monette, Anne, et al.
Publicado: (2015)

Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research
por: Shiku, Hiroshi
Publicado: (2012)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2006)

P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
por: Harada, N, et al.
Publicado: (2014)

Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity
por: Zhang, Yuan, et al.
Publicado: (2015)

Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
por: Chen, Yu, et al.
Publicado: (2015)

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer
por: Qiao, Na, et al.
Publicado: (2015)

Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015)

Human herpesvirus 8 replicates in primary B lymphocytes and induces polyfunctional cytokine and chemokine responses
por: Knowlton, Emilee, et al.
Publicado: (2012)

Engineered microneedle arrays for transcutaneous HIV vaccine delivery
por: DeMuth, P, et al.
Publicado: (2012)

Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
por: Mata-Fink, J, et al.
Publicado: (2012)

The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study
por: Regan, Courtney, et al.
Publicado: (2015)

Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer
por: Champion, Brian R, et al.
Publicado: (2015)

Use of CD200 blockade inhibitor to enhance glioma immunotherapy
por: Mesias, Elisabet, et al.
Publicado: (2015)

Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022)

Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer
por: Sukumar, Madhusudhanan, et al.
Publicado: (2015)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes
por: Dillon, Patrick M, et al.
Publicado: (2013)

Taurine chloramine decreases cell viability and cytokine production in blood and spleen lymphocytes from septic rats submitted to sepsis
por: Dall'Igna, Dhébora Mozena, et al.
Publicado: (2013)

Engineering autoreactive T and B cell responses toward active immunotherapy for inflammatory diseases
por: Chang, Jason Y. H., et al.
Publicado: (2021)

Engineering cytokines for cancer immunotherapy: a systematic review
por: Fu, Yong, et al.
Publicado: (2023)

P04.54. Natural health service: enhancing wellbeing with group walks in green spaces
por: Marselle, M, et al.
Publicado: (2012)

Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT
por: Rapoport, Aaron P, et al.
Publicado: (2013)

Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
por: Regan, Courtney, et al.
Publicado: (2013)

Cancer-specific T cell receptor isolation for cancer immunotherapy
por: Baker, Debbie Emma, et al.
Publicado: (2015)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Recent advances in adoptive cancer immunotherapy in china
por: Zhou, Juhua
Publicado: (2015)

Immunotherapy targeting esophageal cancer stem cells
por: Yue, Dongli, et al.
Publicado: (2013)

Analysis of the transcriptome of CD4 T-Lymphocytes from young Non-Obese Diabetic (NOD) mice suggests a key role for cytokines and apoptosis
por: Kakoola, Dorothy N, et al.
Publicado: (2008)

Interaction between effector and memory cd8+ t cells enhances melanoma adoptive immunotherapy
por: Contreras, Amanda, et al.
Publicado: (2015)

Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment
por: Shang, Lihuan, et al.
Publicado: (2022)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Levy, Ofer, et al.
Publicado: (2014)

Elimination of cytokine and soluble cytokine receptors by carbon sorbents from blood
por: Anisimova, N, et al.
Publicado: (2010)

MDSCs enhance tumor cell proliferation in a caspase-1 related inflammasome cytokines dependent way
por: Zeng, Qi, et al.
Publicado: (2015)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
por: Bedri, Shahinaz, et al.
Publicado: (2014)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o3s10lskn0v81ja53ub22vt5d6